pI: 6.5014 |
Length (AA): 416 |
MW (Da): 45647 |
Paralog Number:
0
Signal peptide: N | GPI Anchor: N | Predicted trans-membrane segments: 0
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
PDB Structures:
Ortholog group members (OG5_126870)
Species | Accession | Gene Product |
---|---|---|
Arabidopsis thaliana | AT3G09810 | Isocitrate dehydrogenase [NAD] catalytic subunit 6 |
Arabidopsis thaliana | AT5G03290 | Isocitrate dehydrogenase [NAD] catalytic subunit 5 |
Brugia malayi | Bm1_13415 | isocitrate dehydrogenase [NAD] subunit alpha, mitochondrial |
Candida albicans | CaO19.10060 | homoisocitrate dehydrogenase |
Candida albicans | CaO19.5791 | isocitrate dehydrogenase |
Candida albicans | CaO19.2525 | homoisocitrate dehydrogenase |
Candida albicans | CaO19.13213 | isocitrate dehydrogenase |
Caenorhabditis elegans | CELE_F43G9.1 | Protein IDHA-1 |
Dictyostelium discoideum | DDB_G0271344 | isocitrate dehydrogenase (NAD+) |
Drosophila melanogaster | Dmel_CG32026 | CG32026 gene product from transcript CG32026-RA |
Drosophila melanogaster | Dmel_CG12233 | lethal (1) G0156 |
Escherichia coli | b1800 | D-malate oxidase, NAD-dependent |
Escherichia coli | b1136 | e14 prophage |
Entamoeba histolytica | EHI_143560 | tartrate dehydrogenase, putative |
Homo sapiens | 3419 | isocitrate dehydrogenase 3 (NAD+) alpha |
Leishmania braziliensis | LbrM.33.2820 | isocitrate dehydrogenase, putative |
Leishmania donovani | LdBPK_332680.1 | isocitrate dehydrogenase, putative |
Leishmania infantum | LinJ.33.2680 | isocitrate dehydrogenase, putative |
Leishmania major | LmjF.33.2550 | isocitrate dehydrogenase, putative |
Leishmania mexicana | LmxM.32.2550 | isocitrate dehydrogenase, putative |
Loa Loa (eye worm) | LOAG_06771 | hypothetical protein |
Mycobacterium leprae | ML1691c | PROBABLE 3-ISOPROPYLMALATE DEHYDROGENASE LEUB (BETA-IPM DEHYDROGENASE) (IMDH) (3-IPM-DH) |
Mus musculus | ENSMUSG00000032279 | isocitrate dehydrogenase 3 (NAD+) alpha |
Mycobacterium tuberculosis | Rv2995c | Probable 3-isopropylmalate dehydrogenase LeuB (beta-IPM dehydrogenase) (IMDH) (3-IPM-DH) |
Mycobacterium ulcerans | MUL_1953 | 3-isopropylmalate dehydrogenase |
Oryza sativa | 4324442 | Os01g0276100 |
Onchocerca volvulus | OVOC6595 |
|
Saccharomyces cerevisiae | YOR136W | isocitrate dehydrogenase (NAD(+)) IDH2 |
Saccharomyces cerevisiae | YIL094C | homoisocitrate dehydrogenase |
Schmidtea mediterranea | mk4.002123.05 | Probable isocitrate dehydrogenase |
Trichomonas vaginalis | TVAG_494040 | isocitrate dehydrogenase, putative |
Wolbachia endosymbiont of Brugia malayi | Wbm0367 | isocitrate dehydrogenase |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
mtu3045 | Mycobacterium tuberculosis | essential | nmpdr |
b1136 | Escherichia coli | essential | goodall |
b1800 | Escherichia coli | non-essential | goodall |
CELE_F43G9.1 | Caenorhabditis elegans | embryonic lethal | wormbase |
CELE_F43G9.1 | Caenorhabditis elegans | slow growth | wormbase |
CELE_F43G9.1 | Caenorhabditis elegans | sterile | wormbase |
CELE_F43G9.1 | Caenorhabditis elegans | terminal arrest variable | wormbase |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.